BusinessMedical DevicesTechnology

Growth and Uptake of Ablation Technologies in Clinical Practice

1 Mins read

Technologies for the therapeutic ablation of tissues are diverse — from ultrasound to electrical, light to radiation — but their common function is to cause the controlled destruction of tissue, either for its excision or simply to remove its aberrant function (as in arrhythmia).

The uptake of the different ablation technologies in clinical practice is driven by the relevance of specific energy types for specific tissue types, the ability to avoid collateral tissue damage, clinician acceptance of manufacturers’ equipment and devices and a variety of other factors.

Technologies for the therapeutic ablation of tissues are diverse — from ultrasound to electrical, light to radiation — but their common function is to cause the controlled destruction of tissue, either for its excision or simply to remove its aberrant function (as in arrhythmia).

The uptake of the different ablation technologies in clinical practice is driven by the relevance of specific energy types for specific tissue types, the ability to avoid collateral tissue damage, clinician acceptance of manufacturers’ equipment and devices and a variety of other factors.

The resulting size of the different ablation market segments, and their growth, is a result of both the historical success each has had in clinical practice and the degree to which these are trending toward continued uptake in therapeutic ablation.

Source: MedMarket Diligence, LLC; Report #A145, “Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities.”

     

183 posts

About author
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Articles
Related posts
Business

Improving Safety in the Workplace: Drone Inspections

3 Mins read
One health-related issue that people don’t think about enough is workplace safety. We previously talked about some steps that can be taken…
Policy & LawTechnology

The Rising Importance of Data Governance and Archiving in Healthcare

3 Mins read
One of the biggest challenges for healthcare organizations, especially as they become more digital, is managing sensitive patient information. With stricter regulations…
eHealthMobile HealthTechnology

Technologies That Can Help You Keep Track of Your Health

3 Mins read
Here and now in the digital age, technology plays a vital role in nearly every part of life. Because maintaining a healthy…